News

TipRanks on MSN19h
GSK’s Promising Study on Belimumab for Lung Disease: What Investors Need to Know
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
TipRanks on MSN2d
GSK’s Promising Study on Belimumab for Systemic Sclerosis Lung Disease
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Infectious Disease Advisor4d
Initiating Belimumab Before Immunosuppressants May Reduce SLE Flares
Use of belimumab prior to vs after initiating immunosuppressants was linked to faster OGC tapering and fewer disease flares among patients with SLE.